SR0735 103RD GENERAL ASSEMBLY

SR0735 LRB103 35953 MST 66040 r

SENATE RESOLUTION

WHEREAS, Many people living with serious mental illnesses, including bipolar disorder, major depressive disorder, schizophrenia, and schizoaffective disorder or gastrointestinal disorders such as gastroparesis, upset stomach, nausea, and vomiting, may be treated with medications that work as dopamine receptor blocking agents, including antipsychotics and antiemetics; and

WHEREAS, While ongoing treatment with these medications can be necessary, prolonged use is associated with tardive dyskinesia (TD), an involuntary movement disorder that is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, and fingers or toes; and

WHEREAS, Even mild symptoms of TD can impact people physically, socially, and emotionally; and

WHEREAS, It is estimated that TD affects approximately 600,000 people in the United States, and approximately 65 percent of people with TD have not been diagnosed, making it important to raise awareness about the symptoms; and

WHEREAS, It is important that people taking these medications be monitored for TD by a healthcare provider; regular screening for TD is recommended by the American Psychiatric Association; and

WHEREAS, Clinical research has led to approval of treatments for adults with TD by the U.S. Food and Drug Administration, and recognition and treatment of TD can make a positive impact in the lives of many people experiencing psychotic and mood disorders; and

WHEREAS, The Illinois Senate can utilize its position to raise awareness of TD among the public and medical community; therefore, be it

RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we declare May 5-11, 2024 as "Tardive Dyskinesia Awareness Week" in the State of Illinois; and be it further

RESOLVED, That we encourage anyone experiencing uncontrollable, abnormal, and repetitive movements to consult their healthcare provider regarding their symptoms.